GL1X · GenesisL1 explorer

MolNFT v1 · #139641 · protein

Mycobacterium tuberculosis pantothenate kinase mutant F254A

5XLV: “Mycobacterium tuberculosis pantothenate kinase mutant F254A”. X-ray diffraction, 1 ligand (SO4), 7 pockets (best druggability 0.86). MolNFT v1 #139641 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5XLV
Type
protein
Length
594 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pantothenate kinase
EC
2.7.1.33
UniProt
P9WPA7
Ligands
SO4
Pockets
7 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APantothenate kinase (EC 2.7.1.33)protein30647% helix, 17% strandP9WPA7
BPantothenate kinase (EC 2.7.1.33)protein28845% helix, 18% strandP9WPA7

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 4 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 38 copies · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains A, B
  • PG4 · Tetraethylene glycol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15590.860.9149EDO
27290.790.8363SO4, PG4, EDO, GOL
35470.730.8152SO4, PG4, EDO
41210.510.8022empty
5900.460.8020empty

Interfaces

1 interface between chains.

  • A–B · 2289 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 5XLV · Mycobacterium tuberculosis Pantothenate kinase mutant F254A · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WPA7 · AlphaFold monomer V2.0 prediction for pantothenate kinase (P9WPA7) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.